TLR2 and bacterial infectious disease: We found that bacterial infection induced extracellular release of CsCKM-1/2, and recombinant CsCKM-1/2 stimulated the activity of peripheral blood leukocytes (PBLs) and exerted antimicrobial effects in a manner that required Toll-like receptor 2 (TLR2).